Mental Health

Shimmer Raises $2.2M for AI-Enhanced ADHD Coaching Platform

The neurodevelopmental condition known as attention-deficit/hyperactivity disorder (ADHD) is massive; according to the renowned ADHD authority, Dr. Russell A. Barkley, Ph.D., 13 million American adults (4-5%) deal with its impacts every day. ADHD may make it difficult to regulate emotions and complete everyday tasks at work and at home. It often leads to anxiety, depression, relationship problems, personal/professional stress and disruption, substance abuse, and…

BeMe Secures $1.5M in Funding from BCBS Kansas to Address Teen Mental Health Crisis

BeMe Health (BeMe), a digital behavioral health platform geared toward teenagers, has secured $1.5M funding investment from Blue Cross and Blue Shield of Kansas (BCBSKS). This strategic partnership aims to provide critical mental health support to approximately 20,000 teenagers across Kansas, where suicide has become the second-leading cause of death among those aged 15 to 24 in the United States. Matt All,…

Behavioral Health Company Uplift Acquires Minded, an Online Psychiatry Practice for Women

UpLift, a behavioral health company, has significantly expanded its reach in the United States by acquiring Minded, an online psychiatry service specializing in women’s care. This strategic move allows UpLift to offer team-based therapy and psychiatry services across all 50 states, starting with California, Illinois, New York, Pennsylvania, and Texas. Previously, UpLift’s operations were limited to a handful of states, including Florida,…

Former Tinder CEO Renate Nyborg Launches Relationship Mentoring App; Announces $3.9M Seed Round

Meeno, a relationship mentoring startup, has successfully raised a $3.9M seed round led by Sequoia Capital, with participation from Andrew Ng’s AI Fund and NEA. The company, formerly known as Amorai, had previously raised funds during its pre-seed round in April (read more here), which brings its total funding to nearly $5M. Meeno, pronounced ‘me-know,’ is an AI-powered relationship mentoring app that…

Equip Extends Its Virtual Eating Disorder Treatment to Adults; Raises Undisclosed Amount from General Catalyst

Equip, a frontrunner in the field of virtual eating disorder treatment, has announced its expansion to include adult patients in the United States. With this move, the company aims to provide comprehensive care and address significant gaps in the traditional treatment landscape. Equip, founded in 2019, has been at the forefront of offering evidence-based treatment to adolescents and young adults struggling with…

Female-led EverBlume Launches with a Mission to Support 40 Million Americans Struggling with Substance Abuse

Woman-led mental health platform EverBlume recently made its debut, positioning itself as an essential sobriety resource for individuals grappling with alcohol-related issues. At a time when substance abuse is rampant — with roughly 40 million Americans aged 12 and up needing treatment for substance abuse disorders in 2020 — resources have become increasingly scarce. EverBlume is stepping up to remedy this gap…

FDA Approves First Oral Treatment for Postpartum Depression

The U.S. Food and Drug Administration (FDA) has approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy. Until now, treatment for PPD was only available as an IV injection given by a healthcare provider in certain healthcare…

SKYLARK Trial Unveils Promising Oral Therapy for Postpartum Depression

The SKYLARK Study, conducted by The Feinstein Institutes for Medical Research at Northwell Health, has shown promising results in treating postpartum depression (PPD). Led by Dr. Kristina M. Deligiannidis, the trial evaluated the efficacy of an investigational oral neuroactive steroid, zuranolone (50mg). The findings suggest zuranolone could become the first oral, at-home therapy approved by the FDA for PPD. The study included…